What is Fauna Bio?
Fauna Bio is a pioneering biotechnology firm dedicated to researching animal genomics. The company's core focus lies in understanding how genetic insights derived from animals can be leveraged to develop improved human therapies. By exploring the intricate connections between animal and human biology, Fauna Bio aims to unlock novel pathways for medical breakthroughs and enhance the efficacy of treatments.
How much funding has Fauna Bio raised?
Fauna Bio has raised a total of $13.1M across 2 funding rounds:
Angel/Seed
$4.1M
Angel/Seed
$9M
Angel/Seed (2019): $4.1M, investors not publicly disclosed
Angel/Seed (2021): $9M led by True Ventures, Boom Capital, and Lifeforce Capital Gp I
Key Investors in Fauna Bio
Lifeforce Capital Gp I
Lifeforce Capital is a venture capital firm. It focuses on identifying and scaling software-driven companies in healthcare. The company was established in 2015.
What's next for Fauna Bio?
The recent major strategic investment positions Fauna Bio for accelerated growth and further research and development initiatives. This infusion of capital is expected to bolster the company's efforts in translating complex genomic data into tangible therapeutic solutions. Fauna Bio is likely to expand its research capabilities, forge strategic partnerships, and advance its pipeline of potential treatments, solidifying its role as a key innovator in the intersection of animal genomics and human health.
See full Fauna Bio company page
